King's College London British Heart Foundation Centre, London, United Kingdom.
Clinic of Pediatrics, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
J Am Soc Echocardiogr. 2024 Mar;37(3):356-363.e1. doi: 10.1016/j.echo.2023.11.013. Epub 2023 Nov 21.
Adults with childhood-onset chronic kidney disease (CKD) have an increased risk of cardiovascular disease. First-phase ejection fraction (EF1), a novel measure of early systolic function, may be a more sensitive marker of left ventricular dysfunction than other markers in children with CKD.
To examine whether EF1 is reduced in children with CKD.
Children from the 4C and HOT-KID studies were stratified according to estimated glomerular filtration rate (eGFR). The EF1 was calculated from the fraction of left ventricular (LV) volume ejected up to the time of peak aortic flow velocity.
The EF1 was measured in children ages 10.9 ± 3.7 (mean ± SD) years, 312 with CKD and 63 healthy controls. The EF1 was lower, while overall ejection fraction was similar, in those with CKD compared with controls and decreased across stages of CKD (29.3% ± 3.7%, 23.5% ± 4.5%, 19.8% ± 4.0%, 18.5% ± 5.1%, and 16.7% ± 6.6% in controls, CKD 1, 2, 3, and ≥ 4, respectively, P < .001). The relationship of EF1 to eGFR persisted after adjustment for relevant confounders (P < .001). The effect size for association of measures of LV structure or function with eGFR (SD change per unit change in eGFR) was greater for EF1 (β = 0.365, P < .001) than for other measures: LV mass index (β = -0.311), relative wall thickness (β = -0.223), E/e' (β = -0.147), and e' (β = 0.141) after adjustment for confounders in children with CKD.
Children with CKD exhibit a marked and progressive decline in EF1 with falling eGFR. This suggests that EF1 is a more sensitive marker of LV dysfunction when compared to other structural or functional measures and that early LV systolic function is a key feature in the pathophysiology of cardiac dysfunction in CKD.
患有儿童期起病的慢性肾脏病(CKD)的成年人患心血管疾病的风险增加。早期射血分数(EF1)是一种评估左心室收缩功能的新指标,与 CKD 患儿的其他指标相比,可能是左心室功能障碍更敏感的标志物。
检查 CKD 患儿的 EF1 是否降低。
根据估算肾小球滤过率(eGFR)将 4C 和 HOT-KID 研究中的儿童分层。EF1 是通过左心室(LV)射血分数的分数来计算的,该分数是从左心室射血速度峰值到峰值的时间内计算得出的。
EF1 在年龄为 10.9±3.7(平均值±标准差)岁的儿童中进行了测量,其中 312 例患有 CKD,63 例为健康对照。与对照组相比,CKD 患儿的 EF1 更低,而整体射血分数相似,并且随着 CKD 阶段的进展而降低(分别为 29.3%±3.7%、23.5%±4.5%、19.8%±4.0%、18.5%±5.1%和 16.7%±6.6%,在对照组、CKD 1、2、3 和≥4 中,P<0.001)。在调整相关混杂因素后,EF1 与 eGFR 的关系仍然存在(P<0.001)。与 eGFR 相关的 LV 结构或功能指标的关联的效应大小(单位 eGFR 变化时的标准差变化)大于 EF1(β=0.365,P<0.001),而其他指标的效应大小小于 EF1:LV 质量指数(β=-0.311)、相对壁厚度(β=-0.223)、E/e'(β=-0.147)和 e'(β=0.141)在调整 CKD 患儿的混杂因素后。
随着 eGFR 的降低,CKD 患儿的 EF1 明显且逐渐下降。这表明,与其他结构或功能指标相比,EF1 是左心室功能障碍的更敏感标志物,并且早期左心室收缩功能是 CKD 心脏功能障碍病理生理学的关键特征。